Free tool
Stocks listed on Nasdaq GM
We cover 58 companies listed on Nasdaq GM. The median market value in the group is $2.50B. Across the group, the median move over the past trading day is −0.42%. 64% of the 58 with a 200-day average trade above it. Price change over the past year runs from −66.5% to +270.5% across the middle 80 percent of the group, with a median of +34.5%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
58 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $9.80B | Mid cap | +146.62% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +62.83% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +9.35% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $6.58B | Mid cap | +555.07% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $6.24B | Mid cap | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $6.18B | Mid cap | +64.11% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +31.96% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.74B | Mid cap | +80.92% |
| CRSP | CRISPR Therapeutics AG | $5.73B | Mid cap | +10.65% |
| TNGX | Tango Therapeutics, Inc. | $4.29B | Mid cap | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $4.26B | Mid cap | +445.10% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.66B | Mid cap | +233.88% |
| VCYT | Veracyte, Inc. Common Stock | $3.56B | Mid cap | +54.81% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +159.74% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +11.97% |
| TMDX | TransMedics Group, Inc. | $3.19B | Mid cap | −21.43% |
| IRON | Disc Medicine, Inc. | $3.17B | Mid cap | +37.90% |
| ZLAB | Zai Lab Limited | $2.92B | Mid cap | −20.06% |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| VERA | Vera Therapeutics, Inc. | $2.65B | Mid cap | +67.21% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.61B | Mid cap | −0.42% |
| TRVI | Trevi Therapeutics, Inc. | $2.55B | Mid cap | +124.00% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +321.09% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| OCUL | Ocular Therapeutix, Inc. | $2.37B | Mid cap | −12.58% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.31B | Mid cap | +4.23% |
| URGN | UroGen Pharma Ltd. | $2.25B | Mid cap | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $2.22B | Mid cap | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.20B | Mid cap | +36.58% |
| VCEL | Vericel Corporation | $2.17B | Mid cap | +18.25% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| XNCR | Xencor, Inc. Common Stock | $2.11B | Mid cap | +254.61% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +32.47% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| HYPR | Hyperfine, Inc. | $92.06M | Micro cap | −29.99% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | −2.69% |
| SERA | Sera Prognostics, Inc. | $82.45M | Micro cap | −26.41% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% |
| BTMD | biote Corp. | $52.54M | Micro cap | −53.87% |
| TCRX | TScan Therapeutics, Inc. | $50.80M | Micro cap | −58.43% |
| TVGN | Tevogen Inc. | $43.63M | Micro cap | −85.43% |
| SNWV | SANUWAVE Health, Inc. | $41.89M | Micro cap | −89.02% |
| YI | 111, Inc. | $32.90M | Micro cap | −46.57% |
| TELA | TELA Bio, Inc. | $31.03M | Micro cap | −60.73% |
| NEUP | Neuphoria Therapeutics Inc. | $20.86M | Micro cap | −62.23% |
| POM | Pomdoctor Limited | $7.08M | Micro cap | −76.43% |
| NOTV | Inotiv Inc | $2.79M | Micro cap | −99.37% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.